BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20690191)

  • 1. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis.
    De Minicis S; Seki E; Paik YH; Osterreicher CH; Kodama Y; Kluwe J; Torozzi L; Miyai K; Benedetti A; Schwabe RF; Brenner DA
    Hepatology; 2010 Oct; 52(4):1420-30. PubMed ID: 20690191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.
    Paik YH; Iwaisako K; Seki E; Inokuchi S; Schnabl B; Osterreicher CH; Kisseleva T; Brenner DA
    Hepatology; 2011 May; 53(5):1730-41. PubMed ID: 21384410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.
    Levin I; Petrasek J; Szabo G
    Alcohol Clin Exp Res; 2012 Aug; 36(8):1397-406. PubMed ID: 22376231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
    Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
    Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases.
    García-Ruiz I; Blanes Ruiz N; Rada P; Pardo V; Ruiz L; Blas-García A; Valdecantos MP; Grau Sanz M; Solís Herruzo JA; Valverde ÁM
    Redox Biol; 2019 Sep; 26():101263. PubMed ID: 31299613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
    Lan T; Kisseleva T; Brenner DA
    PLoS One; 2015; 10(7):e0129743. PubMed ID: 26222337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.
    Inokuchi S; Tsukamoto H; Park E; Liu ZX; Brenner DA; Seki E
    Alcohol Clin Exp Res; 2011 Aug; 35(8):1509-18. PubMed ID: 21463341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review.
    Mortezaee K
    Cell Biochem Funct; 2018 Aug; 36(6):292-302. PubMed ID: 30028028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- mice.
    Mercer KE; Sims CR; Yang CS; Wynne RA; Moutos C; Hogue WR; Lumpkin CK; Suva LJ; Chen JR; Badger TM; Ronis MJ
    Alcohol Clin Exp Res; 2014 Mar; 38(3):672-82. PubMed ID: 24256560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.
    Csak T; Velayudham A; Hritz I; Petrasek J; Levin I; Lippai D; Catalano D; Mandrekar P; Dolganiuc A; Kurt-Jones E; Szabo G
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G433-41. PubMed ID: 21233280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo.
    Jiang JX; Venugopal S; Serizawa N; Chen X; Scott F; Li Y; Adamson R; Devaraj S; Shah V; Gershwin ME; Friedman SL; Török NJ
    Gastroenterology; 2010 Oct; 139(4):1375-84. PubMed ID: 20685364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR2 promotes hepatic fibrosis in mice.
    Seki E; de Minicis S; Inokuchi S; Taura K; Miyai K; van Rooijen N; Schwabe RF; Brenner DA
    Hepatology; 2009 Jul; 50(1):185-97. PubMed ID: 19441102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation.
    Cui W; Matsuno K; Iwata K; Ibi M; Matsumoto M; Zhang J; Zhu K; Katsuyama M; Torok NJ; Yabe-Nishimura C
    Hepatology; 2011 Sep; 54(3):949-58. PubMed ID: 21618578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration.
    Aram G; Potter JJ; Liu X; Wang L; Torbenson MS; Mezey E
    Hepatology; 2009 Mar; 49(3):911-9. PubMed ID: 19072832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
    Jiang JX; Chen X; Serizawa N; Szyndralewiez C; Page P; Schröder K; Brandes RP; Devaraj S; Török NJ
    Free Radic Biol Med; 2012 Jul; 53(2):289-96. PubMed ID: 22618020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NADPH oxidases in liver fibrosis.
    Paik YH; Kim J; Aoyama T; De Minicis S; Bataller R; Brenner DA
    Antioxid Redox Signal; 2014 Jun; 20(17):2854-72. PubMed ID: 24040957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice.
    Motiño O; Agra N; Brea Contreras R; Domínguez-Moreno M; García-Monzón C; Vargas-Castrillón J; Carnovale CE; Boscá L; Casado M; Mayoral R; Valdecantos MP; Valverde ÁM; Francés DE; Martín-Sanz P
    Biochim Biophys Acta; 2016 Sep; 1862(9):1710-23. PubMed ID: 27321932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.
    Yang Z; Sharma AK; Marshall M; Kron IL; Laubach VE
    Am J Respir Cell Mol Biol; 2009 Mar; 40(3):375-81. PubMed ID: 18787174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
    Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.